-
Phosphatase Inhibitor Cocktail 3 Overview
2026-10-07
APExBIO’s K1014 is a 100X phosphatase inhibitor cocktail in DMSO, described as containing Cantharidin, Bromotetramisole, and Calyculin A. No matched research paper was provided, so its scope is limited to the documented product description.
-
Chicken GSDME and RNA Virus-Induced Pyroptosis
2026-10-07
Chen et al. identify chicken GSDME as a major pore-forming effector in RNA virus-associated pyroptosis, addressing the mechanistic gap created by the absence of canonical GSDMD in chicken. Their cell-based evidence connects MDA5 signaling with caspase activation, chGSDME cleavage, pyroptotic cell death, and viral release, while also defining important limits for interpretation beyond DF-1 cells.
-
TUNEL Apoptosis Detection in Pulmonary Hypertension
2026-10-06
A source-grounded overview of TUNEL biology, the One-step TUNEL FITC Apoptosis Detection Kit, and its conceptual relevance to recent pulmonary hypertension research involving nitazoxanide, IMPA1, RAGE, glycolysis, and vascular remodeling.
-
How Axonal CO2 Opens Cx32 in Schwann Cells
2026-10-06
Butler et al. propose that CO2 generated by active axonal mitochondria acts as a metabolic signal that opens Connexin32 hemichannels in the Schwann cell paranode. Using isolated mouse sciatic nerve, imaging, pharmacological perturbation, and a dominant-negative Cx32 construct, the study connects axonal activity with neuron–glia signaling while defining important boundaries for interpreting the mechanism.
-
HIV-1, Pericytes, and Glutamate-Induced DNA Damage
2026-10-05
The reference study shows that HIV-1 infection and latency can make primary brain vascular pericytes more vulnerable to glutamate- and cytokine-associated DNA damage. Its key contribution is to connect latent infection with impaired DNA damage response in a cell type central to blood–brain barrier integrity, while highlighting important limits of an in vitro pseudotyped-virus model.
-
Phosbind Biotin LC: Product Overview
2026-10-04
Phosbind Biotin LC (SKU F4004) is documented by APExBIO as a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes. No matched paper evidence was supplied, so its performance and assay applicability remain unverified here.
-
MTT in Kidney Fibrosis Research: Evidence and Limits
2026-10-03
MTT is a widely used colorimetric metabolic readout, but it should not be treated as a direct measure of cell number, viability, or fibrosis. This overview examines its conceptual role in kidney-fibrosis research, interprets findings from a 2026 epirubicin study, and outlines evidence limitations and applicability boundaries.
-
(+)-Bicuculline: GABAA Protocol Guide
2026-10-02
(+)-Bicuculline is a practical GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, neuronal signaling, and related synaptic responses. This guide covers solvent selection, stock preparation, QC, and interpretation boundaries; it is for scientific research only and not for diagnostic, clinical, or therapeutic use.
-
Urolithin A Workflows for Mitochondrial Research
2026-10-01
Build reproducible Urolithin A assays around mitochondrial quality control, respiratory function, inflammation, and translational muscle biology. This workflow also shows how to examine mitochondrial phenotypes alongside hepatic stellate cell glutamine metabolism without confusing correlation with direct antifibrotic evidence.
-
Multiplexed CRISPR–Cas for Genome Engineering
2026-10-01
This review examines how multiplexed CRISPR–Cas systems expand genome engineering beyond single-locus editing, enabling coordinated gene disruption, large deletions, structural-variant formation, epigenome modulation, and selective cellular stress. Its practical contribution is a framework for matching guide configuration, Cas modality, repair pathway, and validation strategy to the intended biological outcome.
-
Toremifene Versus Tamoxifen in Advanced Breast Cancer
2026-09-30
This Cochrane review synthesized randomized evidence comparing two selective estrogen receptor modulators in advanced breast cancer and found no convincing efficacy advantage for toremifene over tamoxifen. Its practical value lies in separating comparable response and survival outcomes from safety and applicability questions that still require patient-specific interpretation.
-
CAR-M Translation: From Mechanism to Evidence
2026-09-30
A translational analysis of how in situ CAR-macrophage programming, IFN-γ signaling, and CD47–SIRPα checkpoint disruption can be converted into a rigorous experimental strategy, including where Anti-CD4 Antibody (Ibalizumab) may help define immune-cell contributions.
-
EZ Cap™ Mouse IL-7 mRNA for Mechanistic Assays
2026-09-29
EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag) enables controlled cytokine-expression studies with built-in immunodetection potential. This article explains how to use it as a mechanistic perturbation alongside glial, vascular, and SOCS3-focused assays inspired by recent ocular angiogenesis research.
-
Acetaminophen Research Workflows and Controls
2026-09-29
Acetaminophen (paracetamol) provides a versatile pharmacology control for COX-2-associated signaling, oxidative stress, hepatotoxicity research, and ferroptosis-oriented assays. This guide separates dose, solvent, and cell-death effects from the gene-silencing logic used in transthyretin amyloid cardiomyopathy studies.
-
Mitochondrial Calcium Signaling Represses Ferroptosis
2026-09-28
The study links mitochondrial calcium uptake through MCU to acetyl-CoA-dependent GPX4 acetylation, identifying a mechanism that supports GPX4 activity and restrains ferroptosis. Its genetic, biochemical, and structural findings connect ferroptosis control to mitochondrial metabolism and suggest experimental strategies for testing this relationship in cell and tumor models.